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ABSTRACT: There are few biocatalytic transformations that produce fluorine-containing molecules prevalent in modern
pharmaceuticals. To expand the scope of biocatalysis for organofluorine synthesis, we have developed an enzymatic platform for
highly enantioselective carbene B−H bond insertion to yield versatile α-trifluoromethylated (α-CF3) organoborons, an
important class of organofluorine molecules that contain stereogenic centers bearing both CF3 and boron groups. In contrast to
current “carbene transferase” enzymes that use a limited set of simple diazo compounds as carbene precursors, this system based
on Rhodothermus marinus cytochrome c (Rma cyt c) can accept a broad range of trifluorodiazo alkanes and deliver versatile
chiral α-CF3 organoborons with total turnovers up to 2870 and enantiomeric ratios up to 98.5:1.5. Computational modeling
reveals that this broad diazo scope is enabled by an active-site environment that directs the alkyl substituent on the heme CF3-
carbene intermediate toward the solvent-exposed face, thereby allowing the protein to accommodate diazo compounds with
diverse structural features.
Fluorine-containing molecules have assumed a privilegedposition in modern medicine and comprise more than
20% of all pharmaceuticals.1,2 Although many chemical
methods for synthesis of organofluorines have been devel-
oped,3,4 there is a noticeable lack of enzymatic approaches for
their synthesis.5 To expand the scope of biocatalytic fluorine
chemistry, two main strategies are currently considered.5,6 The
first is to expand the substrate scope of natural fluorinase
enzymes via protein engineering. The second is to modify
biosynthetic pathways to accept fluorinated building blocks for
precursor-directed biosynthesis. Although significant progress
has been made,5−13 both approaches suffer from restricted
substrate scope and low efficiency, which hampers synthetic
applications.
A promising strategy to expand the synthetic capability of
nature is to introduce non-natural chemistries into existing
proteins.14−16 Enzymes that share similar mechanistic elements
with non-natural reactions can exhibit promiscuous activities
for abiological reactions, from which new activities can be
evolved.17,18 Here, we used this mechanism-driven approach to
develop fully genetically encoded enzymes that can perform
non-natural reactions for organofluorine synthesis. Our target
transformation is the synthesis of chiral α-trifluoromethylated
(α-CF3) organoborons from trifluorodiazo alkanes and Lewis-
base borane complexes. This class of organofluorine com-
pounds serves as valuable synthetic building blocks that can be
converted to a broad range of CF3-containing molecules via
versatile boron-mediated transformations.19−24 Despite the
synthetic versatility of α-CF3 organoborons, their asymmetric
preparation remains a challenge. The few known enantiose-
lective examples in synthetic chemistry include a copper-
catalyzed asymmetric hydroboration of CF3-substituted
alkenes and enantioselective insertions of CF3-carbene
intermediates into B−H bonds of Lewis-base borane
complexes.21,25 The substrate scopes in both examples are
very limited: the hydroboration approach has only been
applied to aromatic β-CF3-α,β-unsaturated ketones,
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the B−H insertion strategy has only been demonstrated with a
few aryl-substituted trifluorodiazo compounds.25
The deficit of methods for making chiral α-CF3 organo-
borons motivated us to develop an enzymatic platform for their
synthesis by reprogramming heme proteins to utilize
trifluorodiazo alkanes for enantioselective carbene B−H bond
insertion reactions (Figure 1a). Harnessing the facile synthetic
accessibility of trifluorodiazo alkanes26 and the evolvability of
heme proteins,16,27 this platform can be used to prepare a
broad range of chiral α-CF3 organoborons, many of which are
currently unobtainable. The major challenge to developing the
enzymatic system is engineering the heme proteins to
accommodate structurally diverse heme CF3-carbene inter-
mediates for enantioselective B−H bond insertion. Although
current carbene transferases can use a variety of substrates for
versatile chemical transformations,28−43 the scope of diazo
compounds in most of these reactions has been very limited
(mainly to ethyl diazoacetate (EDA)). To expand the diazo
substrate scope, it has usually been necessary to reoptimize the
enzyme active site for each new diazo substrate. Furthermore,
for all synthetic carbene B−H bond insertion reactions
developed to date,44−50 high enantioselectivity has only been
achieved for diazo compounds containing (hetero)aromatic
groups adjacent to the diazo carbon.
We envisioned that these challenges could be met by
leveraging the unique structural features of Rhodothermus
marinus cytochrome c (Rma cyt c).51 This protein has proven
to be a highly versatile platform for developing new enzymatic
carbene-transfer reactions.33,34 The heme-binding pocket of
wild-type Rma cyt c is surrounded by several α-helices, two of
which are connected by a surface loop.51 Recent structural
characterization of the laboratory-evolved Rma cyt c TDE
carbene transferase with a bound iron porphyrin carbene
(IPC) intermediate revealed that the three mutations
introduced during directed evolution rendered this surface
loop (residues 98−103) highly flexible (Figure 1b, left).52 This
enhanced flexibility allows the loop to explore more open
conformations, not observed in the wild-type structure, that
promote interactions between the substrate and the carbene
intermediate. We hypothesized that we could engineer an
active-site environment that favors a constrained conformation
in which the CF3 group of heme CF3-carbene intermediates
Figure 1. (a) Design of a general enzymatic platform for synthesis of chiral α-CF3 organoborons. (b) On the left, overlay of Rma cyt c (PDB 3CP5,
front loop region in blue), Rma TDE (PDB 6CUK, front loop region in orange), and Rma TDE with iron porphyrin carbene structure obtained
from computational modeling (ref 52, front loop region in green). The large change in front loop structure highlights the impact loop mutations
have on access to the active site of Rma cyt c. On the right, we propose that the active-site environment can be tuned to orient the heme-carbene
intermediate such that the alkyl substituent R is solvent-exposed.
Figure 2. (a) X-ray crystal structure of wild-type Rma cyt c (PDB 3CP5). Residues targeted for site-saturation mutagenesis (V75, M99, M100,
M103, and Y44) are shown in sticks. (b) Directed evolution of Rma cyt c for enantioselective synthesis of α-CF3 organoborons with NHC borane 1
and diazo compound 2 as the model substrates. Reactions were performed in M9-N (pH 7.4) suspensions of Escherichia coli cells expressing Rma
cyt c variants (OD600 = 20). Standard reaction conditions were 10 mM borane substrate 1, 7.5 mM diazo substrate 2, room temperature under
anaerobic conditions. Total turnovers (TTN) were defined as the amount of α-CF3 organoboron product divided by the total amount of expressed
Rma cyt c protein as determined by the hemochrome assay. The absolute configuration of product 2a was determined to be R based on the optical
rotation of the derivatized alcohol. See the Supporting Information, section VII, for detailed experimental procedures. wt refers to wild-type Rma
cyt c. Single-letter abbreviations for the amino acid residues: V, Val; S, Ser; M, Met; L, Leu; D, Asp; A, Ala; Y, Tyr; I, Ile.
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points into the heme pocket, and the bulkier alkyl substituent
R faces the solvent-exposed side (Figure 1b, right). In this
conformation, the restricted orientation of the CF3 group
could ensure highly enantioselective formation of C−B bonds
with little or no interference from the alkyl substituent R.
To identify mutations that can stabilize the conformation
proposed in Figure 1b, we began directed evolution of Rma cyt
c with N-heterocyclic carbene (NHC) borane 1 as the model
borane substrate and (3-diazo-4,4,4-trifluorobutyl)benzene (2
in Figure 2) as the model diazo carbene precursor. We
expected that the large phenylethyl group in 2 would facilitate
its positioning toward the solvent-exposed face. While wild-
type Rma cyt c barely catalyzed carbene B−H insertion with 2,
site-saturation mutagenesis (SSM) at residue V75 led to the
discovery of the V75S variant, which afforded the desired
product 2a with 220 total turnovers (TTN) and 80:20
enantiomeric ratio (e.r.). Residue V75 is located on an α-helix
that is close to the heme cofactor and was previously shown to
be a key site for expanding the scope of diazo compounds.33
With Rma cyt c V75S as the parent, we performed additional
rounds of SSM on residues M100, M103, T101, and M99 to
further improve the catalytic performance of this borylation
catalyst. These residues reside on the front loop and are
important for controlling the structure of the heme pocket.52
Through this engineering, we obtained a quadruple mutant,
Rma cyt c V75S M100L M103D M99A (SLDA), which
produced product 2a with 1960 TTN and 96.5:3.5 e.r.
Y44 on the A helix of Rma cyt c is another residue that might
affect catalysis of the target borylation reaction. In an Rma cyt
c-catalyzed carbene Si−H insertion reaction, this residue was
expected to interact with a silane substrate approaching the
enzyme active site, as indicated by the crystal structure of an
Rma cyt c-bound heme-carbene intermediate.52 SSM of the
quadruple mutant SLDA at Y44 and screening yielded the
Y44I mutation that further improved borylation activity to
2460 TTN and enantioselectivity to 97.5:2.5 e.r.
With optimized variant Rma cyt c Y44I V75S M99A M100L
M103D (denoted BOR-CF3) in hand, we next probed its
activity toward a panel of structurally diverse trifluorodiazo
alkanes. If BOR-CF3 stabilizes the “solvent-exposed” con-
formation of the R group as we expect, then it should accept a
wide range of trifluorodiazo alkanes for enantioselective
carbene B−H insertion. Indeed, as shown in Figure 3a,
BOR-CF3 could be used to synthesize a spectrum of α-CF3
organoborons with diverse structural features. High enantio-
selectivity and activity were obtained for diazo compounds
bearing different phenyl substitution patterns (3a−6a).
Extending the chain length of the alkyl substituent R has a
more profound impact on the performance of BOR-CF3 (7a,
8a). Strikingly, reducing the chain length to one carbon in 9a
abolishes borylation activity. As indicated by computational
modeling, the iron-carbene intermediate generated from diazo
9 with a shorter alkyl chain can adopt conformations in which
the phenyl moiety is close to the carbene reaction center.
Unfavorable steric interactions with the phenyl group in these
Figure 3. (a) Scope of trifluorodiazo alkanes for carbene B−H insertion catalyzed by BOR-CF3. Reactions were performed in M9-N (pH 7.4)
suspensions of E. coli cells expressing BOR-CF3 (OD600 = 20). Standard reaction conditions were 10 mM borane substrate 1, 7.5 mM diazo
substrate n, room temperature under anaerobic conditions. The absolute configuration of 2a was determined to be R based on the optical rotation
of the derivatized alcohol (see the Supporting Information, section VII). (b) Preparative scale synthesis (0.2 mmol scale) and the derivatization of
2a to boronic acid 2c.
ACS Central Science Research Article
DOI: 10.1021/acscentsci.8b00679
ACS Cent. Sci. 2019, 5, 270−276
272
conformations would inhibit the borane substrate’s approach
to the carbene (see Figure S6 in the Supporting Information).
We further challenged BOR-CF3 with trifluorodiazo alkanes
containing alkyl chains without aromatic groups (10−13).
Although these diazo compounds are structurally distinct from
the model compound 2 used for directed evolution, BOR-CF3
can still effectively convert them into α-CF3 organoborons with
730−1630 TTN and 96:4−98:2 e.r. (10a−13a). This result
shows that the high enantioselectivity of BOR-CF3 does not
require specific recognition of the aromatic substituent. One
synthetic advantage of this method is that the trifluorodiazo
alkane starting compounds can be synthesized easily from a
variety of starting materials such as alkyl halides, aldehydes,
and carboxylic acids.26,53,54 As these compounds are widely
present in nature, this method could provide a facile way to
obtain chiral organoborons that contain motifs of complex
natural products. To demonstrate this, we synthesized
trifluorodiazo compound 13 bearing a geranyl structural
motif. Subjecting 13 to the standard conditions described in
Figure 3 with BOR-CF3 as the catalyst afforded organoboron
product 13a with 1630 TTN and 98:2 e.r. Given the
prevalence of the geranyl structural motif in bioactive
Figure 4. (a) The hydrogen bonding interactions between 75S and 71Y amide backbone and the empty surface area in a representative snapshot
obtained from MD trajectories of BOR-CF3 in the absence of diazo compound (see also Figures S1 and S2 in the Supporting Information). (b)
Binding pose of diazo substrate 2 bound into the active site of BOR-CF3, obtained from docking and constrained MD simulations (see Figure S3
and computational details in the SI). Direct comparison between the shape of the BOR-CF3 active site and the docked diazo 2 shows the high
complementarity achieved by evolution and introduction of V75S mutation. (c) Comparison of diazo 2 bound in the BOR-CF3 structure and the
DFT-optimized model transition state (TS) geometry for formation of the iron porphyrin carbene (IPC) intermediate (see the SI, Figure S8). The
diazo 2 in this binding pose represents a near attack conformation that leads to the transition state for the generation of the iron porphyrin carbene
intermediate.
Figure 5. (a) Overlay of snapshots extracted from a 500 ns MD trajectory of BOR-CF3-bound trifluoroalkyl-carbene intermediate 2b (see also
Figures S4 and S5 in the Supporting Information). (b) Representative snapshots of the two main conformations explored by trifluoroalkyl-carbene
intermediate 2b in BOR-CF3 during MD trajectories. Blue surface represents the inner void cavity generated in the protein active site next to the
iron porphyrin carbene. (c) DFT-optimized transition state (TS) for B−H carbene insertion in a model system (see also Figure S7). Key distances
and angles are given in Å and degrees.
ACS Central Science Research Article
DOI: 10.1021/acscentsci.8b00679
ACS Cent. Sci. 2019, 5, 270−276
273
molecules,55 this organoboron compound may find applica-
tions in syntheses of fluorinated analogues of natural products
such as pheromones. To further demonstrate the synthetic
utility of our method, we performed this biocatalytic
transformation on preparative scale and obtained borane
product 2a in 52% isolated yield and 97:3 e.r. The NHC
borane 2a can be readily converted to the boronic acid 2c
while retaining the stereochemistry of the boron-substituted
chiral center, which would facilitate its further derivatization to
other chiral trifluoromethyl-containing molecules.
We next used molecular dynamics (MD) simulations to
obtain further insights into the stereocontrol imposed by the
enzyme and the roles of the introduced mutations. Analysis of
the active-site shape of BOR-CF3 in the absence of both
substrates revealed that the hydroxyl group in the 75S side
chain forms a hydrogen bond with the Y71 amide backbone,
which directs the Cβ hydrogen of serine to face toward the
heme (Figure 4a). Modeling of the active-site structure of
BOR-CF3 with a bound diazo compound 2 showed that this
serine arrangement generates more space at the heme distal
side to better accommodate the CF3 group. As a result, diazo
compound 2 can mainly be docked in one specific
conformation in the BOR-CF3 active site (Figure 4b).
Intriguingly, this conformation is structurally analogous to
the transition state for iron-carbene generation via N2 loss
(Figure 4c). This result suggests that the active-site environ-
ment of BOR-CF3 not only constrains the conformation of the
trifluorodiazo alkane, but also promotes the formation of the
iron-carbene intermediate by facilitating the interaction
between the diazo compound and the heme iron center.
We further modeled the BOR-CF3-bound trifluoroalkyl-
carbene intermediate 2b formed from diazo compound 2. MD
simulations revealed that 2b can adopt two major con-
formations as shown in Figure 5a,b. The main difference
between the two conformers is the slight rotation of the Fe−C
bond, which is possible because no specific contacts between
the CF3 group and the protein stabilize one conformation over
the other. Nonetheless, in both conformations, the CF3 group
is pointing into the active site, and the bulkier phenyl group
lies between the M103D and Y44I side chains and is exposed
to the solvent, in line with our original hypothesis. More
interestingly, both conformers of 2b expose the same pro-R
face of the carbene intermediate to the empty volume
generated in the active site, consistent with the observed R
absolute configuration of product 2a. To better understand the
interaction between the borane substrate 1 and the carbene
intermediate 2b, we used DFT calculations to describe the
transition state (TS) for B−H carbene insertion using a model
iron porphyrin system (see the SI, section VIII, for
computational details). A structural comparison between this
TS geometry and the structure of protein-bound carbene
intermediate 2b revealed that borane 1 can be effectively
accommodated in the empty volume of 2b where it can adopt
a catalytically competent pose to reach the TS for C−B bond
formation (TS-CB). In this reaction scheme, the newly
introduced M99A and M100L mutations alter the conforma-
tional dynamics of the front loop and generate an appropriate
binding pocket for borane substrate 1 in the carbene-bound
enzyme, while the major role of M103D and Y44I is to
facilitate binding of the diazo substrate and stabilize both the
diazo and the carbene intermediate in this binding pose.
Notably, in this interaction mode, the alkyl substituent R on
the CF3-carbene intermediate should have little influence on
how the borane substrate approaches the carbene intermediate,
which explains the general high enantioselectivity exhibited by
BOR-CF3 for most trifluorodiazo alkanes tested. The generality
of this rationale for other trifluorodiazo alkanes is suggested by
the catalytic performance of BOR-CF3 and its earlier variants
on geranyl-containing diazo compound 13, where the trend in
activity and enantioselectivity was similar to that with model
diazo compound 2 (Scheme S1 in the Supporting
Information).
In conclusion, we have developed a biocatalytic platform for
synthesis of chiral α-CF3 organoborons. Using directed
evolution, we created an active site in Rma cyt c that can
host structurally diverse trifluorodiazo alkanes for highly
enantioselective carbene B−H insertion reactions. The effects
of beneficial mutations on the catalytic activities and
conformational dynamics have been rationalized by computa-
tional modeling. These efforts have expanded the scope of
carbene intermediates accessible to heme proteins and
provided new mechanistic insights into enzymatic carbene-
transfer reactions.
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